Oxcarbazepine Suspension
Product Images NDC 67877-532

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 67877-532). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oxcarbazepine-1 (Oxcarbazepine 1)

FDA Label Image

Oxcarbazepine-10 (Oxcarbazepine 10)

FDA Label Image

Oxcarbazepine-11 (Oxcarbazepine 11)

FDA Label Image

Oxcarbazepine-12 (Oxcarbazepine 12)

FDA Label Image

Oxcarbazepine-13 (Oxcarbazepine 13)

FDA Label Image

Oxcarbazepine-14 (Oxcarbazepine 14)

FDA Label Image

Oxcarbazepine-15 (Oxcarbazepine 15)

This text seems to be a table displaying time to exit in days for a treatment group in two categories: HIGH and Low. The numbers at the top appear to represent time intervals or durations. The table likely provides data on how long it takes for subjects in each treatment group to exit within those time frames.*

FDA Label Image

Oxcarbazepine-16 (Oxcarbazepine 16)

FDA Label Image

Oxcarbazepine-17-a (Oxcarbazepine 17 A)

This is a description of Oxcarbazepine Oral Suspension, USP, a medication that contains 300 mg of oxcarbazepine USP per 5 mL. The pharmacist should dispense it with the medication guide enclosed or provided separately. It is important to shake well before using and store it in the original container at 25°C (77°F) with excursions permitted to 15-30°C (59-86°F). It is for oral use only and should be kept out of the reach of children. The bottle should be used within 7 weeks of first opening. The product is manufactured by Alkem Laboratories Ltd., India, and distributed by Ascend Laboratories, LLC.*

FDA Label Image

Oxcarbazepine-18-a (Oxcarbazepine 18 A)

Dosage: See package insert. Store at 25°C (77°F); excursions permitted to 15-30°C (59°F to 86°F). Suspension, USP 300 mg/5 ml. Shake well before using. Each 5 mL contains 300 mg oxcarbazepine USP. Keep out of reach of children. 250 mL bottle. Manufactured by: Akem Laboratories. Distributed by: Ascend Laboratories, LLC. Important: Dispense with medication guide enclosed.*

FDA Label Image

Oxcarbazepine-2 (Oxcarbazepine 2)

FDA Label Image

Oxcarbazepine-3 (Oxcarbazepine 3)

FDA Label Image

Oxcarbazepine-4 (Oxcarbazepine 4)

FDA Label Image

Oxcarbazepine-5 (Oxcarbazepine 5)

FDA Label Image

Oxcarbazepine-6 (Oxcarbazepine 6)

FDA Label Image

Oxcarbazepine-7 (Oxcarbazepine 7)

FDA Label Image

Oxcarbazepine-8 New (Oxcarbazepine 8 New)

FDA Label Image

Oxcarbazepine-9 New (Oxcarbazepine 9 New)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.